Literature DB >> 24604576

The relationship between hypotension, cerebral flow, and the surgical field during endoscopic sinus surgery.

Thanh Ngoc Ha1, Robert Graham van Renen, Guy L Ludbrook, Rowan Valentine, Judy Ou, Peter-John Wormald.   

Abstract

OBJECTIVES/HYPOTHESIS: Hypotensive anesthesia is often used in endoscopic sinus surgery (ESS) to improve surgical visibility; however, its safety and efficacy in this role are yet to be justified. This study aimed to evaluate the effect of hypotensive anesthesia on both real-time middle cerebral artery blood flow velocity (Vmca) and the severity of surgical bleeding in patients undergoing ESS. STUDY
DESIGN: Prospective, observational cohort study.
METHODS: Thirty-two patients undergoing hypotensive anesthesia for ESS at a single tertiary institution during February 2011 to July 2012 were recruited for the study. Transcranial Doppler ultrasonography measured periodic Vmca, which were time-matched for hemodynamic and respiratory factors. One-minute video segments corresponding with each Vmca reading were randomized and distributed to two blinded observers for bleeding assessment.
RESULTS: Three hundred and fifty-six data time points were recorded for systolic, diastolic, and mean arterial blood pressure (MAP), pulse rate, respiratory rate, end-tidal carbon dioxide concentration, Vmca, and bleeding assessment score (BAS). A direct relationship exists between MAP and Vmca (r = 0.77, P < .0001) as well as MAP and BAS (r = 0.36, P < .0001). MAP levels above 60 mm Hg maintained at least 50% of baseline Vmca flow in almost 90% of all time points.
CONCLUSIONS: Hypotensive anesthesia is an effective method of controlling intraoperative bleeding during endoscopic sinus surgery; however the effect is clinically small in low MAP ranges. In otherwise healthy patients undergoing ESS with general anesthesia, reducing MAP to below 60 mm Hg may increase the risk of cerebral ischemia.
© 2014 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Endoscopic sinus surgery; bleeding score; hypotensive anesthesia; intraoperative bleeding; middle cerebral artery blood flow velocity; transcranial Doppler ultrasonography

Mesh:

Year:  2014        PMID: 24604576     DOI: 10.1002/lary.24664

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Range of S-100β levels during functional endoscopic sinus surgery with moderately controlled hypotension.

Authors:  Youngsuk Kwon; Ji Su Jang; Sung Mi Hwang; Jae Jun Lee; Jun Ho Lee; Sungmin Joo; In-Gon Lee; Sung Jun Hong
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-29       Impact factor: 2.503

Review 2.  Transnasal endoscopic skull base surgery in the COVID-19 era: Recommendations for increasing the safety of the method.

Authors:  Tomasz Lyson; Joanna Kisluk; Marek Alifier; Barbara Politynska-Lewko; Andrzej Sieskiewicz; Jan Kochanowicz; Joanna Reszec; Jacek Niklinski; Marek Rogowski; Joanna Konopinska; Zenon Mariak; Ricardo L Carrau
Journal:  Adv Med Sci       Date:  2021-03-04       Impact factor: 2.852

Review 3.  Perioperative management of endoscopic transsphenoidal pituitary surgery.

Authors:  Martin Hanson; Hao Li; Eliza Geer; Sasan Karimi; Viviane Tabar; Marc A Cohen
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-03-20

4.  Evaluation of cerebral oxygen saturation during hypotensive anesthesia in functional endoscopic sinus surgery.

Authors:  Behrooz Farzanegan; Majid Golestani Eraghi; Samira Abdollahi; Jahangir Ghorbani; Ali Khalili; Reza Moshari; Alireza Jahangirifard
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Oct-Dec

5.  Comparison of the effect of propofol and desflurane on S-100β and GFAP levels during controlled hypotension for functional endoscopic sinus surgery: A randomized controlled trial.

Authors:  Ji Su Jang; Youngsuk Kwon; Sung Mi Hwang; Jae Jun Lee; Jun Suck Lee; Soo Kyoung Lee; Ho Seok Lee
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.